A 7-year-old child with Down syndrome and disruptive behaviors

J Dev Behav Pediatr. 2007 Apr;28(2):151-4. doi: 10.1097/01.DBP.0000267565.57070.94.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Anxiety Agents / adverse effects
  • Anti-Anxiety Agents / therapeutic use
  • Attention Deficit and Disruptive Behavior Disorders / chemically induced
  • Attention Deficit and Disruptive Behavior Disorders / diagnosis*
  • Attention Deficit and Disruptive Behavior Disorders / psychology
  • Child
  • Comorbidity
  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Down Syndrome / diagnosis*
  • Down Syndrome / psychology
  • Heart Defects, Congenital / diagnosis
  • Heart Defects, Congenital / psychology
  • Hospitalization
  • Humans
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / drug therapy
  • Hypertension, Pulmonary / psychology
  • Lorazepam / adverse effects
  • Lorazepam / therapeutic use
  • Male
  • Oxygen Inhalation Therapy
  • Piperazines / adverse effects
  • Piperazines / therapeutic use
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / psychology
  • Purines / adverse effects
  • Purines / therapeutic use
  • Risk Factors
  • Sildenafil Citrate
  • Sulfones / adverse effects
  • Sulfones / therapeutic use
  • Vasodilator Agents / adverse effects
  • Vasodilator Agents / therapeutic use

Substances

  • Anti-Anxiety Agents
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate
  • Lorazepam